Bär & Karrer Advises Mitsui on the Acquisition of Chemtrade Aglobis

On 28 February 2017, Mitsui & Co., Ltd. (Mitsui) and Chemtrade Logistics Inc. (Chemtrade) announced an agreement under which Mitsui will acquire the entire stake in Chemtrade Aglobis AG (Aglobis), subsidiary entirely owned by Chemtrade. Aglobis is a leading distributor of sulphur and sulphuric acid in Europe. The transaction is subject to relevant regulatory approvals.

Bär & Karrer Advises Lonza on the Entering into a Strategic Partnership with Sanofi to Establish a

Today, Lonza and Sanofi announced that they have entered into a strategic partnership to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland. The large-scale facility will be established through a joint venture with an initial investment of around CHF 290 million shared equally between Lonza and Sanofi. …

Bär & Karrer on top of the Profile League Table by Mergermarket

Earlier this month Mergermarket published its review on the 2016's most prolific individual DACH legal advisors. We are pleased to be ranked with Christoph Neeracher and Luca Jagmetti on the top of the table on rank one and two. Both are associated for 2016 with 11 completed deals and a total value of EUR 3 …

Bär & Karrer Advises Valora on the Acquisition of Pretzel Baron

Bär & Karrer Advises Valora on the Acquisition of Pretzel Baron

Bär & Karrer Advises Priora on Acquisition of Large Minority Stake in Galenica

Bär & Karrer Advises Priora on Acquisition of Large Minority Stake in Galenica

Bär & Karrer Advises Sanofi on Exchange Transaction with Boehringer Ingelheim

Bär & Karrer Advises Sanofi on Exchange Transaction with Boehringer Ingelheim

Bär & Karrer Advises Pax Anlage on the Public Takeover Offer of Baloise

Bär & Karrer Advises Pax Anlage on the Public Takeover Offer of Baloise

Bär & Karrer Advises Alpine Select on Public Share Buy-back

Bär & Karrer Advises Alpine Select on Public Share Buy-back. On 10 January 2017, Alpine Select Ltd, Zug, invited to an extraordinary shareholders' meeting which will take place on 7 February 2017. At this shareholders' meeting, the shareholders will, among other things, vote on a capital reduction through the cancellation of shares which have been …